Clinical Trial Update: Development of PHY606 as Adjunct Therapy for Anemia Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on PHY606 as adjunct therapy for anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• PHY606

Snippet

Sponsor: Sheng-Teng Huang | Conditions: Anemia, Herbal Interaction | Phase 3 | Status: COMPLETED